FIELD: medicine, oncology. SUBSTANCE: proposed medicinal agent is a mixture of 2-4 g DL-valine and small nontherapeutic dose of methyltestosterone (0.020-0.025 g) at effect on the hormone-sensitive cancer tumors in women and a mixture of 2-4 g DL-valine, 0.005-0.010 g metandrostenolone and 0.3-0.5 g phthivazide for effect on the hormone-nonsensitive cancer tumors. EFFECT: high effectiveness of treatment, absence of by-side effects. 9 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD TO TREAT MALIGNANT TUMORS IN ANIMALS | 1998 |
|
RU2180841C2 |
| REMEDY HAVING ADAPTOGENIC ACTIVITY | 1992 |
|
RU2038077C1 |
| METHOD FOR DIAGNOSING MALIGNANT DISEASES AND THEIR PROLAPSES | 1992 |
|
RU2039985C1 |
| METHOD OF TREATING ADVANCED AND RECURRENT SKIN CANCER | 2008 |
|
RU2393879C1 |
| METHOD FOR TREATMENT OF TRANSLABLE CONNECTIVE TISSUE SARCOMA M-1 IN RATS WITH COMBINED IMPACT OF PHOTODYNAMIC THERAPY AND RADIOTHERAPY | 2021 |
|
RU2763663C2 |
| AGENT SHOWING ANTITUMOR EFFECT | 2001 |
|
RU2185819C1 |
| PHARMACOLOGICAL COMBINATION OF POLYCATIONIC CARRIER PEG-PEI-TAT WITH INCLUDED IN IT PLASMID CARRYING THERAPEUTIC GENES HSVtk AND GM-CSF FOR GENE THERAPY OF TUMOROUS DISEASES | 2013 |
|
RU2575077C2 |
| METHOD OF TREATING MALIGNANCIES IN MAMMALS | 2011 |
|
RU2461566C1 |
| COMBINATION THERAPY | 2018 |
|
RU2815400C2 |
| COMBINED APPLICATION OF ECTEINASCIDIN-743 AND PLATINUM-CONTAINING ANTI-TUMOUR COMPOUNDS | 2004 |
|
RU2391101C2 |
